Bone metastasis in pulmonary sclerosing hemangioma

por Kim, Min Kyoung, Jang, Se-Jin, Kim, Yong Hee, Kim, Sang-We
Publicado 2015

Does Pemetrexed Work in Targetable, Nonsquamous Non-Small-Cell Lung Cancer? A Narrative Review

por Shih, Jin-Yuan, Inoue, Akira, Cheng, Rebecca, Varea, Rocio, Kim, Sang-We
Publicado 2020

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer

por Cho, Su Han, Yoon, Shinkyo, Lee, Dae Ho, Kim, Sang-We, Kim, Kwoneel
Publicado 2021

Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

por Roh, Yun Hwa, Park, Ji Eun, Kang, Sora, Yoon, Shinkyo, Kim, Sang-We, Kim, Ho Sung
Publicado 2023

False-Positive Hypermetabolic Lesions on Post-Treatment PET-CT after Influenza Vaccination

por Kim, Jeong-Eun, Kim, Eun Kyoung, Lee, Dae Ho, Kim, Sang-We, Suh, Cheolwon, Lee, Jung-Shin
Publicado 2011

Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment

por Kim, Dal Yong, Lee, Dae Ho, Jang, Sun-Joo, Kim, Sang-We, Suh, Cheolwon, Lee, Jung Shin
Publicado 2011

Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma

por Kim, Jwa Hoon, Yoon, Shinkyo, Lee, Dae Ho, Jang, Se Jin, Chun, Sung‐Min, Kim, Sang‐We
Publicado 2021

Clinicopathologic Characteristics of T-cell Non-Hodgkin's Lymphoma: A Single Institution Experience

por Ko, Ock Bae, Lee, Dae Ho, Kim, Sang We, Lee, Jung Shin, Kim, Shin, Huh, Jooryung, Suh, Cheolwon
Publicado 2009

Epidermal Growth Factor Receptor (EGFR) Expression in Operable Non-small Cell Lung Carcinoma

por Ahn, Jin-Hee, Kim, Sang-We, Hong, Seung-Mo, Suh, Cheolwon, Kim, Woo Kun, Lee, In Chul, Lee, Jung-Shin
Publicado 2004

Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment

por Choi, Myeong Geun, Choi, Chang-Min, Lee, Dae Ho, Kim, Sang-We, Yoon, Shinkyo, Ji, Wonjun, Lee, Jae Cheol
Publicado 2022

Angiosarcomas of the Bilateral Breast and Heart: Which One is the Primary Site?

por Kim, Eun Kyoung, Park, Ik-Soo, Sohn, Byeong Seok, Kim, Jeong Eun, Lee, Dae Ho, Kim, Sang-We, Suh, Cheolwon
Publicado 2012

A Case of Residual Non-Small Cell Lung Cancer Cells Coexisting With Newly Developed Small Cell Lung Cancer Cells in Ascitic Fluid after Chemotherapy for Non-Small Cell Lung Cancer

por Park, Sang Hyuk, Chi, Hyun-Sook, Kim, Young Jin, Cho, Young-Uk, Jang, Seongsoo, Park, Chan-Jeoung, Kim, Sang-We
Publicado 2014

Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clin...

por Choi, Yoon Ji, Lee, Dae Ho, Choi, Chang Min, Lee, Jung Shin, Lee, Seung Jin, Ahn, Jin-Hee, Kim, Sang-We
Publicado 2015

Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment

por Jang, Yoon Jung, Hyun, Dong-gon, Ji, Wonjun, Choi, Chang-Min, Yoon, Shinkyo, Lee, Dae Ho, Kim, Sang-We, Lee, Jae Cheol
Publicado 2023

Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis

por Hyun, Dong-gon, Choi, Chang-Min, Lee, Dae Ho, Kim, Sang-We, Yoon, Shinkyo, Kim, Woo Sung, Ji, Wonjun, Lee, Jae Cheol
Publicado 2020

Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study

por Choi, Myeong Geun, Choi, Chang-Min, Lee, Dae Ho, Kim, Sang-We, Yoon, Shinkyo, Kim, Woo Sung, Ji, Wonjun, Lee, Jae Cheol
Publicado 2021

Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer

por Kim, Yeon Joo, Song, Si Yeol, Jeong, Seong-Yun, Kim, Sang We, Lee, Jung-Shin, Kim, Su Ssan, Choi, Wonsik, Choi, Eun Kyung
Publicado 2015

Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study

por Kato, Hidenori, de Souza, Paul, Kim, Sang-We, Lickliter, Jason D., Naito, Yoichi, Park, Keunchil, Kumar, Sanjeev, Mugundu, Ganesh M., Bang, Yung-Jue
Publicado 2020

Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor

por Kwon, Byoung Soo, Cho, Young Hyun, Yoon, Shin‐Kyo, Lee, Dae Ho, Kim, Sang‐We, Kwon, Do Hoon, Lee, Jae Cheol, Choi, Chang‐Min
Publicado 2020

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung

por Jang, Yoon Jung, Hyun, Dong-gon, Choi, Chang-Min, Lee, Dae Ho, Kim, Sang-We, Yoon, Shinkyo, Kim, Woo Sung, Ji, Wonjun, Lee, Jae Cheol
Publicado 2021